Hi Glyco,
The ability to distinguish quality research varies from one individual to another. How potential investors interpret company news boils down to how experienced they are in moving around a Prospectus, Annual Report, 1/2 yearly, 4C and any releases from the company.
The delay in the CFDA Approval is frustrating and Dr G will be pulling his hair out with setback after setback from the Chinese government. Could this whole approval process be done differently, only Dr G could answer this conundrum.
IMHO GMV is still a company that has the potential to be a major global player in the Health Care Sector. Dr G has been building his workforce as he developes the company in different regions and he is primed to attack as soon as the CFDA Approval comes through.
GMV is not a train wreck but is a high risk buy at this stage. Good luck to all.
DYOR GLTAH
Cheers Rubes
- Forums
- ASX - By Stock
- GMV
- Ann: US Listing Update
Ann: US Listing Update, page-56
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)